Formation of covalently linked C3-C3 dimers on IgG immune aggregates (Q45240676)

11 December 2017

title

Formation of covalently linked C3-C3 dimers on IgG immune aggregates (English)

1 reference

11 December 2017

Barrio E

1

1 reference

11 December 2017

Antón LC

2

1 reference

11 December 2017

Marqués G

3

1 reference

11 December 2017

Sánchez A

4

1 reference

11 December 2017

Vivanco F

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 February 1991

1 reference

European Journal of Immunology

11 December 2017

published in

1 reference

11 December 2017

volume

21

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

343-349

1 reference

The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

The binding of human complement component C4 to antibody-antigen aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

The covalent-binding reaction of complement component C3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

Appearance of covalently bound antigen in immune complexes formed during the activation of complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

The activation mechanism of the alternative pathway of the human complement system by the immune precipitate formed with F(ab')2 of rabbit IgG antibody: the generation of C3- and C5-cleaving enzymes on the immune precipitate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

Covalent association of C3b with C4b within C5 convertase of the classical complement pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

Structural requirements of rabbit IgG F(ab')2 fragment for activation of the complement system through the alternative pathway--I. Disulfide bonds

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

A method of trace iodination of proteins for immunologic studies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

Interaction between the third complement protein and cell surface macromolecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

Structural characterization of factor I mediated cleavage of the third component of complement.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

Human complement component C3: cDNA coding sequence and derived primary structure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210215

7 January 2021

Identifiers

DOI

10.1002/EJI.1830210215

1 reference

11 December 2017

1 reference